| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.100 | None | 0.889 | 2 | 0 | 2008 | 2019 | |||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2 | 0.599 | 0.615 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2001 | 2016 | |||||||||
|
MIR155 host gene | 0.617 | 0.615 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2017 | |||||||||
|
defensin alpha 1 | 0.636 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
H19 imprinted maternally expressed transcript | 0.494 | 0.923 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
immunoglobulin heavy variable 1-69 | 0.729 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | |||||||||
|
insulin dependent diabetes mellitus 8 | 0.821 | 0.192 |
|
disease | 0.030 | None | 0.667 | 1 | 0 | 2000 | 2010 | |||||||||
|
microRNA 132 | 0.485 | 0.846 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2019 | |||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2008 | 2019 | |||||||||
|
microRNA 16-1 | 0.623 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
T cell receptor beta locus | 0.636 | 0.538 |
|
disease | 0.050 | None | 0.800 | 1 | 0 | 1994 | 2003 | |||||||||
|
selectin P | 0.460 | 0.769 | 5.0E-32 |
|
disease | 0.040 | None | 0.750 | 1 | 0 | 2007 | 2018 | ||||||||
|
inositol 1,4,5-trisphosphate receptor type 2 | 0.631 | 0.654 | 5.7E-29 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
centromere protein J | 0.546 | 0.846 | 2.1E-27 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
vasoactive intestinal peptide receptor 1 | 0.573 | 0.654 | 7.4E-27 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
endo-beta-N-acetylglucosaminidase | 0.861 | 0.231 | 4.4E-25 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
complement C5 | 0.550 | 0.731 | 8.1E-24 |
|
disease | 0.160 | None | 1.000 | 2 | 0 | 2007 | 2013 | ||||||||
|
adenosine monophosphate deaminase 1 | 0.573 | 0.692 | 1.9E-21 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.700 | None | 0.899 | 20 | 0 | 2004 | 2019 | ||||||||
|
Fc receptor like 3 | 0.612 | 0.769 | 6.0E-21 |
|
disease | 0.200 | None | 0.857 | 5 | 0 | 2005 | 2016 | ||||||||
|
solute carrier family 11 member 1 | 0.525 | 0.846 | 1.5E-19 |
|
disease | 0.400 | None | 0.938 | 3 | 0 | 1996 | 2019 | ||||||||
|
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase | 0.576 | 0.731 | 3.0E-19 |
|
disease | 0.340 | None | 1.000 | 1 | 0 | 2004 | 2016 | ||||||||
|
NLR family pyrin domain containing 1 | 0.502 | 0.769 | 5.0E-19 |
|
disease | 0.050 | None | 0.800 | 1 | 0 | 2008 | 2017 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.100 | None | 0.982 | 2 | 0 | 1992 | 2019 | ||||||||
|
matrix metallopeptidase 13 | 0.452 | 0.923 | 7.9E-18 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 1996 | 2020 |